An environment of relentless challenge and change is the norm for pharmaceutical and life sciences companies. Despite critical need and high demand for its products, the industry remains under pressure from physicians, patients, payers and regulators to deliver more effective treatments at lower cost. Its current business model, based on development and marketing of blockbuster drugs, is increasingly economically unsustainable and operationally unsuited to the kind of quick action needed to meet complex stakeholder demandsThe Indian healthcare market is one of the prominent contributors to the country’s gross domestic product (GDP) having attracted large number of players- domestic as well as international – during the past few years. Highly qualified doctors and scientists, state-of-the-art technology and low costs have helped India become an attractive global destination for medical tourism, clinical studies, and research and development (R&D) programs.

The sector offers massive growth potential and a chance to capitalize on its expansion, especially as the country sees a rise in the incidence of lifestyle-related diseases. A growing elderly population paired with a rise in income levels also emphasise the need for better facilities in the country.

The sector comprises the hospitals and allied sectors such as diagnostics and pathology, medical equipment and supplies, and medical tourism

Representative Searches

• Leading Pharma Company: Head Logistics
• Leading Pharma Company: Head Quality
• Leading Pharma Company: Head Government Affairs
• Leading Pharma Company: India Sales Marketing Manager